A doctor at the centre of a review of the treatment of more than 200 patients with lung disease is being investigated by the ...

Niigata, Japan – Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial ...

A team of researchers have applied a novel blood test that can detect early signs of potentially fatal lung damage in cancer ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

Access to the live webcasts will be available to investors and other interested parties via Liquidia’s website at https://liquidia.com/investors/events-and-presentations. An archived, recorded version ...

New study introduces a simple blood test to detect early lung damage in cancer patients receiving novel therapy with antibody ...

Liquidia LQDA is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what investors should know before the release. Analysts are estimating that Liquidia ...

The N-AVD regimen showed improved progression-free survival and lower toxicity than BV-AVD in advanced Hodgkin lymphoma, ...

Creative Planning acquired a new stake in Liquidia Co. (NASDAQ:LQDA – Free Report) during the third quarter, HoldingsChannel reports. The firm acquired 17,023 shares of the company’s stock, valued at ...

Accordingly, cellular senescence and inflammaging have emerged as potential pathophysiology mechanisms of interstitial and obstructive lung diseases. Age is also a significant risk factor for certain ...

It’s possible to catch a cold or get the flu at any time of year. But the chances of becoming sick increase during cold and ...